NYSE American - Delayed Quote USD
Myomo, Inc. (MYO)
3.2000
-0.1600
(-4.76%)
At close: May 9 at 4:00:00 PM EDT
3.1600
-0.04
(-1.25%)
After hours: May 9 at 7:53:36 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
32,551.1990
32,551.1990
19,241.1580
15,555.2290
13,856.3740
Cost of Revenue
9,365.8560
9,365.8560
6,058.7750
5,302.1330
3,544.0970
Gross Profit
23,185.3430
23,185.3430
13,182.3830
10,253.0960
10,312.2770
Operating Expense
29,392.0410
29,392.0410
21,413.9320
20,925.3000
20,580.3420
Operating Income
-6,206.6980
-6,206.6980
-8,231.5490
-10,672.2040
-10,268.0650
Net Non Operating Interest Income Expense
388.5860
388.5860
410.2740
88.7310
1.6120
Other Income Expense
--
--
-170.2880
-67.6120
-16.9480
Pretax Income
-5,818.1120
-5,818.1120
-7,991.5630
-10,651.0850
-10,283.4010
Tax Provision
365.6170
365.6170
156.0020
69.9370
88.9280
Net Income Common Stockholders
-6,183.7290
-6,183.7290
-8,147.5650
-10,721.0220
-11,012.2820
Diluted NI Available to Com Stockholders
-6,183.7290
-6,183.7290
-8,147.5650
-10,721.0220
-11,012.2820
Basic EPS
-0.23
-0.16
-0.28
-1.52
-1.89
Diluted EPS
-0.23
-0.16
-0.28
-1.52
-1.89
Basic Average Shares
36,865.8480
37,758.8370
29,499.3400
7,051.4470
5,830.3530
Diluted Average Shares
36,865.8480
37,758.8370
29,499.3400
7,051.4470
5,830.3530
Total Operating Income as Reported
-6,206.6980
-6,206.6980
-8,231.5490
-10,672.2040
-10,268.0650
Total Expenses
38,757.8970
38,757.8970
27,472.7070
26,227.4330
24,124.4390
Net Income from Continuing & Discontinued Operation
-6,183.7290
-6,183.7290
-8,147.5650
-10,721.0220
-10,372.3290
Normalized Income
-6,183.7290
-6,183.7290
-8,147.5650
-10,721.0220
-10,372.3290
Interest Income
388.5860
388.5860
410.2740
88.7310
1.6120
Interest Expense
--
--
--
--
15.3360
Net Interest Income
388.5860
388.5860
410.2740
88.7310
1.6120
EBIT
-6,206.6980
-6,206.6980
-8,231.5490
-10,672.2040
-10,268.0650
EBITDA
-5,429.7270
-5,429.7270
-7,713.8680
-10,129.5770
-9,932.1020
Reconciled Cost of Revenue
9,365.8560
9,365.8560
6,058.7750
5,302.1330
3,544.0970
Reconciled Depreciation
776.9710
776.9710
517.6810
542.6270
335.9630
Net Income from Continuing Operation Net Minority Interest
-6,183.7290
-6,183.7290
-8,147.5650
-10,721.0220
-10,372.3290
Total Unusual Items Excluding Goodwill
-49.8600
--
--
--
0
Total Unusual Items
-49.8600
--
--
--
0
Normalized EBITDA
-5,429.7270
-5,429.7270
-7,713.8680
-10,129.5770
-9,932.1020
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/12/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DCTH Delcath Systems, Inc.
14.84
+3.38%
LFWD Lifeward Ltd.
1.3700
0.00%
RCEL AVITA Medical, Inc.
6.97
-25.29%
AXGN Axogen, Inc.
11.37
-9.73%
ECOR electroCore, Inc.
4.6500
-10.40%
CVRX CVRx, Inc.
4.7700
-38.69%
CLPT ClearPoint Neuro, Inc.
14.11
-0.98%
AXDX Accelerate Diagnostics, Inc.
0.1480
+7.25%
APYX Apyx Medical Corporation
1.1600
-1.69%
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%